Fresenius Medical Care AG & Co. KGaA (FMS)
Automate Your Wheel Strategy on FMS
With Tiblio's Option Bot, you can configure your own wheel strategy including FMS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol FMS
- Rev/Share 66.4351
- Book/Share 52.8423
- PB 0.9541
- Debt/Equity 0.7529
- CurrentRatio 1.461
- ROIC 0.0365
- MktCap 13712830337.5704
- FreeCF/Share 6.7587
- PFCF 6.9149
- PE 22.1833
- Debt/Assets 0.3306
- DivYield 0.0253
- ROE 0.0438
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
FMS or RXST: Which Is the Better Value Stock Right Now?
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or RxSight, Inc. (RXST). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency
Published: June 17, 2025 by: Benzinga
Sentiment: Positive
Fresenius Medical Care AG FMS on Tuesday introduced a strategic roadmap — FME Reignite — aimed at revitalizing its core business, driving innovation and reshaping its organizational culture.
Read More
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Negative
FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.
Read More
Fresenius (FMS) Upgraded to Buy: Here's Why
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Fresenius (FMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History
Published: May 22, 2025 by: PRNewsWire
Sentiment: Neutral
Shareholders approved the proposed dividend of 1.44 Euro per share, representing a 21 percent increase year-over-year and marking the highest dividend in the company's history Excellent progress in the company's transformation and turnaround plans continues to strengthen the foundation for sustainable, profitable growth In 2024, organic revenue growth1 was 4 percent, and operating income increased by 18 percent on an outlook base2, coming in at the upper end of the company's outlook The company is well positioned for double digit earnings growth in 2025, translating to an 11-12 percent margin BAD HOMBURG, Germany , May 22, 2025 /PRNewswire/ -- Fresenius …
Read More
Here's Why Fresenius (FMS) is a Strong Value Stock
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Fresenius (FMS) is a Great Momentum Stock: Should You Buy?
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Fresenius (FMS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Five high-flying medical instrument stocks are: DXCM, IDXX, NPCE, CLPT, FMS.
Read More
New Strong Buy Stocks for May 9th
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive
CBNA, FMS, BNTGY, WYY and BCRX have been added to the Zacks Rank #1 (Strong Buy) List on May 9, 2025.
Read More
Best Value Stocks to Buy for May 9th
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive
BNTGY, SSUMY and FMS made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 9, 2025.
Read More
Best Income Stocks to Buy for May 9th
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive
SSUMY and FMS made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 9, 2025.
Read More
FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Fresenius Medical's first-quarter results showcase a strong segmental performance, along with reiterating its 2025 outlook for revenue growth.
Read More
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Fresenius Medical Care starts 2025 with strong organic revenue and income growth
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral
Strong organic revenue growth1 of 5% driven by Care Enablement and Care Delivery Stable U.S. same market treatment development despite impact from a severe flu season FME25 savings of EUR 68 million contributed to earnings Operating income2 grew 11% at constant currency resulting in margin expansion Reported operating income grew by 35% and reported net income3 by 113% Net leverage ratio further improved to 2.8x and FY 2025 outlook confirmed BAD HOMBURG, Germany , May 6, 2025 /PRNewswire/ -- "The results of the first quarter of 2025 once again demonstrate our continuous operational and financial progress as we are executing …
Read More
Fresenius Medical Care tops market expectations in 1st quarter
Published: May 06, 2025 by: Reuters
Sentiment: Positive
World's largest dialysis specialist Fresenius Medical Care reported first-quarter results above analysts' expectations on Tuesday, as revenue grew organically in all its segments, it said.
Read More
Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Positive
MedTech companies' quarterly results are likely to reflect strength in customer demand. Let's see how FMS, MASI and CLOV are placed ahead of their earnings releases.
Read More
Should You Buy, Sell, or Hold FMS Stock Before Q1 Earnings?
Published: May 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Fresenius Medical Care heads into the first quarter of 2025 with momentum from cost savings, innovation like the 5008X launch, and a steady recovery in U.S. treatment volumes.
Read More
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
Published: April 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Here's Why Fresenius (FMS) is a Strong Value Stock
Published: April 17, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Why Fresenius Medical Care Stock Might be a Great Pick
Published: April 17, 2025 by: Zacks Investment Research
Sentiment: Positive
FMS has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Read More
4 Top-Ranked High Earnings Yield Value Stocks to Buy Right Away
Published: April 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Unlock your portfolio value with value stocks like Alibaba, Fresenius Medical, Helix Energy and Heritage Insurance. All these stocks boast high earnings yield.
Read More
Here's Why Fresenius (FMS) is a Strong Momentum Stock
Published: April 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Negative
In the present market turbulence, investors may want to consider discounted stocks, such as FMS, PAHC and COR.
Read More
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Negative
FMS continues to gain traction on the back acquisitions & partnerships. A tough regulatory environment raises concerns.
Read More
4 Stocks Trading Near 52-Week High With More Upside Potential
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Stocks like TAP, FMS, TGI and THG are seeing price strength and have a high chance of carrying the momentum forward.
Read More
4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Neutral
Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility.
Read More
5 Relative Price Strength Stocks to Navigate Today's Market
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive
IHS, ANIP, MD, FMS and TREE are five stocks with explosive relative price strength.
Read More
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
4 Best Value Stocks With Low PEG to Boost Your Portfolio Returns
Published: March 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Here are four PEG-driven value stocks that fit our screening criteria: JD, UHS, FMS, and QFIN.
Read More
About Fresenius Medical Care AG & Co. KGaA (FMS)
- IPO Date 1996-09-17
- Website https://www.freseniusmedicalcare.com
- Industry Medical - Care Facilities
- CEO Ms. Helen Giza
- Employees 112035